Germany Animal Vaccine Market to Reach $1,618.1 million in 2035, Growing at 6.5% CAGR

Germany animal vaccine market valued at $867.2 million in 2025 and is projected to reach $1,618.1 million by 2035, growing at a CAGR of 6.5% during the forecast period (2026-2035). The Germany animal vaccine market comprises preventive biological products used in livestock (cattle, pigs, poultry, sheep) and companion animals (dogs, cats, small mammals, birds) to control infectious diseases, support biosecurity, and improve animal health and productivity. Sustained demand is driven by Germany’s large livestock base, strong regulatory frameworks, proactive disease control programs, and high companion animal ownership. Government agencies such as the Federal Ministry of Food and Agriculture (BMEL), the Federal Office of Consumer Protection and Food Safety and the Federal Statistical Office play vital roles in animal health surveillance, vaccination policy, regulatory approvals, and disease reporting.

Browse the full report description of “Germany Animal Vaccine Market Size, Share & Trends Analysis Report by Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/germany-animal-vaccine-market

Key Numbers & Animal Populations

• Pigs (swine): ~21.5 million head on German farms as of November 3, 2025.
• Cattle (including dairy and beef): ~10.5 million head as of November 3, 2025.
• Sheep: ~1.5 million head as of November 3, 2025.

Key Innovators Driving Germany Animal Vaccine Transformation

The key players in the Germany animal vaccine market include Elanco Animal Health Incorporated, Merck Animal Health, Phibro Animal Health Corporation, Virbac S.A., Zoetis Inc, among others.

• In May 2025, Boehringer Ingelheim expanded its veterinary vaccine manufacturing operations in Germany to support supply chain capacity and meet growing demand for livestock vaccines in Europe.
• In March 2025, Zoetis introduced updated companion animal vaccine formulations in Germany, designed to provide extended immunity and simplified dosing for veterinary use.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Technology
• Competitive Landscape - Elanco Animal Health Incorporated, Merck Animal Health, Phibro Animal Health Corporation, Virbac S.A., Zoetis Inc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Germany Animal Vaccine Market Report Segment

By Type

• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
• Aquaculture Vaccines
• Companion Animal Vaccines
• Other

By Technology

• Live Attenuated Vaccine
• Killed/Inactive Vaccine
• Recombinant Vaccine
• Vectored Vaccine
• Subunit Vaccine
• DNA Vaccine
• Chimeric Vaccine
• Others

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/germany-animal-vaccine-market